Regulation of Humoral Immunity to Influenza Virus
流感病毒体液免疫的调节
基本信息
- 批准号:8068104
- 负责人:
- 金额:$ 3.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAntibodiesAntibody FormationAntigensAntiviral AgentsAntiviral ResponseB Cell ProliferationB-Lymphocyte SubsetsB-LymphocytesBiologyCD4 Positive T LymphocytesCellsChimera organismCollaborationsDataDefectDevelopmentEnzyme-Linked Immunosorbent AssayFigs - dietaryFlushingFundingGoalsGrantGraphHumoral ImmunitiesITGAX geneImmuneImmunityImmunizationImmunoglobulin AIn VitroIndividualInfectionInfluenzaInterferon-betaInterferonsKnockout MiceKnowledgeMediatingMemoryMethodsModelingMusNatureOutcomePathologyPhysiologicalProcessProtocols documentationPublished CommentPublishingReceptors, Antigen, B-CellRegulationReportingResearchRespiratory SystemRespiratory tract structureRoleSerumShapesSignal TransductionStimulusStructure of germinal center of lymph nodeT cell responseT-Cell ReceptorT-LymphocyteTLR3 geneTLR7 geneTestingTextTissuesToll-like receptorsTransgenic MiceVirusVirus DiseasesVoiceWorkWritingbasehuman TLR3 proteinin vivoinfluenzavirusirradiationlymph nodesnovel vaccinesprogramsresponse
项目摘要
in part by studies conducted during the initial funding period of this
grant, suggests that immediate early exposure of B cells to infection-induced innate
signals shape the responses of B cells. Little is known about the nature of these
signals and the mechanisms by which they affect the B cell response. The working
hypothesis to be tested here is that infection-induced local innate immune signals
differentially regulate various B cell subsets involved in the induction of protective
immunity to influenza virus infection. The long-term objective of the studies is to
determine how respiratory tract immunity to viral infections is induced and regulated. The
objective of this proposal is to determine the mechanisms by which innate immune
signals, particularly type I IFN shape the quality and magnitude of antiviral B cell
responses. This is based on studies during the last funding period which showed type I
IFN as a major infection-induced B cell stimulus in regional lymph nodes within 2 days of
infection. To achieve our objective three Specific Aims will be carried out. Specific Aim
#1 will determine the mechanisms by which direct IFNR-signals received by B cells
affect the magnitude and protective capacity of individual B cell response components to
influenza: B-1 cells, extrafollicular foci and germinal center responses. Specific Aim #2
will determine the role of toll-like receptor (TLR) 3 and 7-mediated signals on antiviral B
cell response regulation to influenza infection and their integration with stimuli provided
by the B cell receptor and/or T cell help. In Specific Aim #3 the effects of IFNR-mediated
B cell stimulation on local CD4 T cell responses to influenza virus infection and particular
the affects on CD40-CD40L mediated help will be investigated. In vitro and in vivo tests
are aided by the use of virus-specific T cell receptor transgenic mice. Completion of
these studies will contribute to a better understanding of the processes that regulate the
induction of protective antiviral B cell responses to influenza virus.
Project Description Page 6
部分原因是在本项目最初供资期间进行的研究,
格兰特的研究表明,B细胞在感染诱导的先天性
信号塑造B细胞的反应。关于这些的性质知之甚少
信号及其影响B细胞应答的机制。工作
这里要检验的假设是,感染诱导的局部先天免疫信号
差异调节各种B细胞亚群参与诱导保护性
对流感病毒感染免疫。研究的长期目标是
确定呼吸道对病毒感染的免疫是如何诱导和调节的。的
这项建议的目的是确定先天免疫的机制,
信号,特别是I型干扰素塑造抗病毒B细胞的质量和数量
应答这是基于上一个供资期间的研究,
IFN作为局部淋巴结中主要感染诱导的B细胞刺激物在感染后2天内
感染为了实现我们的目标,我们将实现三个具体目标。具体目标
#1将确定由B细胞接收的直接IFNR信号的机制
影响单个B细胞应答组分的大小和保护能力,
流感:B-1细胞、滤泡外病灶和生发中心反应。具体目标#2
将确定Toll样受体(TLR)3和7介导的信号对抗病毒B的作用
细胞对流感感染的应答调节及其与提供的刺激的整合
受到B细胞受体和/或T细胞的帮助。在具体目标#3中,IFNR介导的
B细胞刺激对局部CD 4 T细胞对流感病毒感染应答的影响
将研究对CD 40-CD 40 L介导的帮助的影响。体外和体内测试
通过使用病毒特异性T细胞受体转基因小鼠来辅助。完成
这些研究将有助于更好地了解调节
诱导针对流感病毒保护性抗病毒B细胞应答。
项目描述第6页
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicole Baumgarth其他文献
Nicole Baumgarth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicole Baumgarth', 18)}}的其他基金
Antibody-mediated immunity to Borrelia burgdorferi
抗体介导的伯氏疏螺旋体免疫
- 批准号:
10368140 - 财政年份:2021
- 资助金额:
$ 3.19万 - 项目类别:
Antibody-mediated immunity to Borrelia burgdorferi
抗体介导的伯氏疏螺旋体免疫
- 批准号:
10559504 - 财政年份:2021
- 资助金额:
$ 3.19万 - 项目类别:
Antibody-mediated immunity to Borrelia burgdorferi
抗体介导的伯氏疏螺旋体免疫
- 批准号:
10731568 - 财政年份:2021
- 资助金额:
$ 3.19万 - 项目类别:
B-1 cells, IgM and Protective Humoral Immunity to Influenza
B-1 细胞、IgM 和流感保护性体液免疫
- 批准号:
10681028 - 财政年份:2019
- 资助金额:
$ 3.19万 - 项目类别:
B-1 cells, IgM and Protective Humoral Immunity to Influenza
B-1 细胞、IgM 和流感保护性体液免疫
- 批准号:
10023157 - 财政年份:2019
- 资助金额:
$ 3.19万 - 项目类别:
Protective humoral immunity to influenza infection
对流感感染的保护性体液免疫
- 批准号:
9196008 - 财政年份:2016
- 资助金额:
$ 3.19万 - 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
- 批准号:
8521064 - 财政年份:2010
- 资助金额:
$ 3.19万 - 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
- 批准号:
8316175 - 财政年份:2010
- 资助金额:
$ 3.19万 - 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
- 批准号:
8134252 - 财政年份:2010
- 资助金额:
$ 3.19万 - 项目类别:
Long-lived B cell Immunity in the Respiratory Tract
呼吸道中的长寿命 B 细胞免疫
- 批准号:
8009552 - 财政年份:2010
- 资助金额:
$ 3.19万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 3.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 3.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 3.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




